AHR Short Interest Hits One-Year High Before Q3 Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Short interest in AHR has climbed to 19.2% of free float, the highest level recorded in at least a year, rising 56% over the past month and nearly 10% in the past week alone. That pace of accumulation is the standout number heading into Thursday's Q3 results. The stock itself has held up, closing at $53.52, up 1% on Friday and roughly 3% over the past month. The borrow market remains loose despite the short buildup: availability is running at 425%, meaning roughly four shares are available to borrow for every one already shorted, and the cost to borrow is just 0.45%. The ORTEX short score has edged up to 68.1, a level that places AHR in roughly the 95th percentile for short pressure within its sector.
Options positioning tells a different story. The put/call ratio has dropped to 0.23, well below its 20-day average of 0.31 and close to the lower end of its one-year range. Call volume is running ahead of puts, which is the opposite of what you would expect if equity-options traders were aligning with short sellers. The divergence between a rapidly growing short position and call-heavy options activity is the central tension in the setup.
The analyst community is uniformly constructive. Every rated analyst carries a buy-equivalent, and Raymond James initiated coverage at Strong Buy with a $62 target on October 13. UBS and Barclays both trimmed targets modestly on the same date, to $62 and $60 respectively, while maintaining positive ratings. The mean target of $63.69 implies roughly 19% upside from Friday's close. The bull case centres on $600 million in expected 2026 acquisitions, a projected two-year CAGR above 11% for seniors housing and skilled nursing, and improving Medicare reimbursement rates. Bears focus on tenant default risk, regulatory uncertainty in skilled nursing, and a PE multiple above 58x that leaves little room for execution slippage.
AHR held up better than most peers over the past week. Closest comparable VTR fell 2.3% over the same period. WELL dropped 1.1%. CTRE and NHI were broadly flat, while OHI and LTC added 1.6% and 2.3% respectively. AHR's 0.9% weekly gain sits at the better end of that range. BlackRock remains the largest disclosed holder at 11.2% of shares as of late September, having trimmed from 13.2% earlier in the year. The CFO sold $1.27 million of stock in an open-market transaction in late June, a trade not made under a pre-arranged 10b5-1 plan.
Thursday's print will test whether the Trilogy segment's occupancy trajectory and the pace of acquisitions justify the widening gap between the analyst consensus and a short position that has expanded sharply in the weeks leading up to the result.
Stocks in this article
See the live data behind this article on ORTEX.
Open AHR on ORTEX →How this article was generated
- Generated
- 2 Nov 2026, 04:25
- Data as of
- 2 Nov 2026, 04:04
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.